Navigation Links
Array BioPharma Reports New Clinical Data on Its Anti-Inflammatory,Drugs

hat regulates the biosynthesis of the inflammatory cytokines TNF, IL-6 and IL-1. Array scientists have discovered potent MEK inhibitors that interfere with these biosynthetic processes. We have previously advanced one MEK inhibitor, ARRY-886, into clinical development for the treatment of cancer. Given our experience with the safety profile of MEK inhibitors, we believe inhibition of MEK will have broad applications in diseases driven by IL-1 and TNF. ARRY-162, an orally active MEK inhibitor, has shown significant efficacy and is well tolerated in preclinical models of human arthritis and other inflammatory diseases.

About ARRY-797 / Targeting p38 for Inflammation and Cancer

P38 is a kinase target that regulates the production of numerous pro-inflammatory cytokines, in particular, TNF, IL-6 and IL-1. These cytokines can also act as cellular growth factors and are often up-regulated in certain cancers including prostate, ovarian and multiple myeloma. Additionally, p38 may play a role in certain resistance mechanisms or metastatic progression in cancer.

About Array BioPharma:

Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat life-threatening and debilitating diseases. Our proprietary drug development pipeline is focused on the treatment of cancer and inflammatory disease and includes clinical candidates that are designed to regulate therapeutically important targets. In addition, leading pharmaceutical and biotechnology companies collaborate with Array to discover and develop drug candidates across a broad range of therapeutic areas. For more information on Array, please go to www.arraybiopharma.com.

Array BioPharma's Forward-Looking Statement

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to future clinical test
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
2. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
3. DOR BioPharma Announces Issuance of European Patent for Its Oral Multivalent Botulinum Toxin Vaccine BT-VACC
4. DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC
5. PDL BioPharma Announces Long-Term Nuvion Data Presented at 2007 Digestive Disease Week
6. AVI BioPharma Reports Positive Pre-Clinical Influenza Data
7. Helix BioPharma Corp. Announces Positive Phase II Clinical Results with its Topical Interferon Alpha-2b
8. CeNeRx BioPharma Announces Positive Phase I Results in First Human Trial of Third Generation RIMA Antidepressant
9. Integrated BioPharmas Proprietary Vaccine Technology Achieves Strong Positive Results
10. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
11. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
Post Your Comments:
(Date:6/18/2013)... , June 18, 2013  Intercept Pharmaceuticals, Inc.  (NASDAQ: ... focused on the development and commercialization of novel bile ... the pricing of an underwritten public offering of 1,730,000 ... price of $33.01 per share.  In addition, Intercept has ... to an additional 259,500 shares of common stock. ...
(Date:6/18/2013)... PROSPECT, Ill. , June 18, 2013 /PRNewswire-iReach/ ... of its new X3130 Appliance Inlet Module. The ... circuit breaker , combines a C14 appliance inlet ... one compact package.  This three-in-one device allows design ... their designs - cutting installation time by 66 ...
(Date:6/18/2013)... ROCKY HILL, Conn. , June 18, 2013 ... many past clients of Alliance Seating and Mobility, ... now unable to access timely repair. This appears ... and a dramatic reduction of field service employees.  ... Unfortunately a great many of these clients ...
Breaking Medicine Technology:Intercept Pharmaceuticals Announces Pricing of Public Offering of Common Stock 2Three-in-One X3130 Appliance Inlet Module 2
... Mylan Inc. (Nasdaq: MYL ) today ... final approval from the U.S. Food and Drug Administration ... Pantoprazole Sodium Delayed-release (DR) Tablets USP, 20 mg (base) ... Protonix® DR Tablets, a treatment for the irritation of ...
... ICAP Ocean Tomo , the ... the world,s premier patent auction firm, announces the sale ... Consisting of seven issued patents and seven related applications ... to companies involved in areas such as lighting, x-ray, ...
Cached Medicine Technology:Cutting Edge Nanotech Patents for Displays, Lighting, X-ray, Medical Imaging, and Diagnostics Available for Sale by ICAP Ocean Tomo 2
(Date:6/19/2013)... FL (PRWEB) June 19, 2013 Ultimate ... Children's Telethon, an 11.5-hour broadcast on WFLA News Channel ... has collected more than $84 million for All Children's ... 2013, event, themed "30 Years of Miracles," marked the ... hour, 18 UMA employees worked the phones during the ...
(Date:6/19/2013)... (PRWEB) June 19, 2013 Next ... a premier kids entertainment media organization, and ... games company, will be introducing the Games for ... The 3D game is geared toward students in ... and active lifestyles by rewarding positive choices. The ...
(Date:6/19/2013)... Riverside, CA (PRWEB) June 19, 2013 Recently, ... Arc of Riverside County held their third in a series ... the National Wall of Respect and helped place the mosaic tiles ... Erin Maxwell and her parents, Cathy and Greg Maxwell. , ... result of an idea that took root over three years ago ...
(Date:6/19/2013)... 2013 Maui'd Forever , Hawaii's ... being an effective and cost effective way to provide ... partnered up with Tom Barefoot’s Tours providing an activity ... of Hawaii’s activities. , They have just released a ... the lowest prices on their Hawaii activities. , ...
(Date:6/19/2013)... June 19, 2013 According to Transparency ... Market Share, Trends, Analysis and Forecast, 2011 – 2017,” ... billion in the year 2011 and is expected to ... CAGR of 9.7% from 2011 to 2017. Flexible endoscopes ... contributing about USD 2,201 million for the year 2011. ...
Breaking Medicine News(10 mins):Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 2Health News:Ultimate Medical Academy Rallies in Support of All Children's Hospital 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 2Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 3Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 4Health News:Adventure Game for Tweens to Promote Healthy Eating will be Unveiled at Games For Health Conference 5Health News:Arc Creates Huge Mosaic Mural to Highlight the Need for Greater Respect of People with Disabilities 2Health News:Maui'd Forever Pleased to Offer Price Guarantee on Hawaii Activities 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 2Health News:Endoscopy Devices Market Will Reach USD 10.8 Billion in 2017 : Transparency Market Research 3
... The Simmons firm, a leading national law firm in the ... second Miles for Meso 5K run/walk on Sunday, October 11, ... at www.milesformeso.org . , The Simmons ... 26 in Alton, Ill. Nearly 500 runners and walkers registered, ...
... ... the return of PRE-PEN® penicillin allergy skin testing products to the market. PRE-PEN® received ... with AllerQuest to market and distribute PRE-PEN®. , ... Round Rock, TX (PRWEB) September 30, 2009 -- ALK-Abelló, ...
... play a role, expert contends, , WEDNESDAY, Sept. 30 (HealthDay ... of surgery, not just the rate of those complications, determines ... , The study, which included more than 84,000 people who ... difference in surgical deaths between hospitals with the lowest rate ...
... , CARLSBAD, Calif., Sept. 30 Jenny Craig, Inc., one ... actress and comedian Nicole Sullivan as the newest Jenny Craig ... gave birth to her second child in August 2009, is ... 35 pounds. , (Photo: http://www.newscom.com/cgi-bin/prnh/20090930/NY84610 ...
... 30 Healthcare Realty Trust Incorporated (NYSE: HR ) ... credit facility, which replaces the previous $400 million facility. ... 2012. The facility is priced at 2.80% over LIBOR, ... terms and conditions customary for loans of this nature. ...
... among those with OCD or Tourette syndrome ... have suggested that strep throat may cause or trigger ... has found no evidence of a link. , ... much rarer neuropsychiatric disorders," Dr. Anette Schrag of the ...
Cached Medicine News:Health News:Simmons Law Firm Presents Second 'Miles for Meso' Walk/Run Fundraiser for Mesothelioma Research 2Health News:FDA Approves PRE-PEN Penicillin Allergy Test 2Health News:Surgical Deaths Linked to Handling of Complications 2Health News:Surgical Deaths Linked to Handling of Complications 3Health News:Nicole Sullivan Joins Jenny Craig to Reclaim Her Pre-Baby Body 2Health News:Healthcare Realty Trust Announces New $550 Million Unsecured Revolving Credit Facility 2Health News:Study Debunks Link Between Strep and Brain Disorders 2
Immersion oils may crystallize on storage. Can be redissolved on heating to 50ºC (1-2 hours)...
Immersion oil for microscopy...
... Type DF is the highest resolution ... microscopy and it also exhibits extremely ... FF has virtually zero fluorescence and ... oil of choice when low levels ...
... - the ones to compare with, the ones ... in the development and standardization of immersion oil ... , When the FDA set general purpose reagent ... in the 1970's, Cargille Immersion Oils were already ...
Medicine Products: